VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 1572847
Sex: U
Age:
State:

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: bruising at injection site; itching at the injection site; Swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported.). On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. No concomitant medications reported. No treatment information provided.

Other Meds:

Current Illness:

ID: 1572848
Sex: F
Age:
State:

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swelling; This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE SWELLING (swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history). On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced INJECTION SITE SWELLING (swelling). At the time of the report, INJECTION SITE SWELLING (swelling) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. No concomitant medications reported. No treatment information provided.

Other Meds:

Current Illness:

ID: 1572849
Sex: F
Age: 70
State: TX

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swelling, erythema, hot to touch; expanded skin that looks like cellulitus; little itchiness; little itchiness; swelling; erythema; arm soreness; This spontaneous case was reported by a physician and describes the occurrence of in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. N/A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included AMOXICILLIN from 23-Jan-2021 to an unknown date for Antibiotic level, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN HYDROCHLOROTHIAZIDE ACTAVIS) for Hypertension. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment included Zyzal

Other Meds: LOSARTAN HYDROCHLOROTHIAZIDE ACTAVIS; AMOXICILLIN.

Current Illness:

ID: 1572850
Sex: F
Age: 62
State: CA

Vax Date: 01/13/2021
Onset Date: 01/14/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: was tested positive for Covid; had fever; was tired; sore left arm; A spontaneous report was received from a consumer concerning a 62-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) experienced sore left arm, had fever, was tired, was tested positive for Covid. The patient's medical history was not provided. Concomitant medications reported were calcium. On 13/Jan/2021 prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 14/Jan/2021, the patient experienced sore left arm. On 22-JAN-2021 the patient experienced had fever and was tired. On 24/Jan/2021 the patient experienced was tested positive for Covid. Treatment medications were not reported. Action taken with mRNA-1273 in response to the events was not reported. The events, sore left arm, was considered resolved on 24 Dec 2020. The outcome of the events had fever, was tired, was tested positive for Covid was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of pain in arm, pyrexia and fatigue, a causal relationship cannot be excluded. Based on the current available information and the mechanism of action of mRNA-1237 vaccine, the event of COVID-19 is assessed as unlikely related.

Other Meds: CALCIUM

Current Illness:

ID: 1572851
Sex: F
Age: 66
State: FL

Vax Date: 01/29/2021
Onset Date: 01/30/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Injection site arm got sore; Very fatigued; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Injection site arm got sore), FATIGUE (Very fatigued) and HEADACHE (Headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. No Medical History information was reported. On 29-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced FATIGUE (Very fatigued) and HEADACHE (Headache). On an unknown date, the patient experienced VACCINATION SITE PAIN (Injection site arm got sore). At the time of the report, VACCINATION SITE PAIN (Injection site arm got sore), FATIGUE (Very fatigued) and HEADACHE (Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication list was not provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1572852
Sex: F
Age: 43
State: PA

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Odd taste in mouth; Body aches; Feverish feeling with no temperature; Chills; Injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Odd taste in mouth), PAIN (Body aches), FEELING HOT (Feverish feeling with no temperature), CHILLS (Chills) and VACCINATION SITE PAIN (Injection site pain) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. El1284) for COVID-19 vaccination. Concurrent medical conditions included Asthma. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced DYSGEUSIA (Odd taste in mouth), PAIN (Body aches), FEELING HOT (Feverish feeling with no temperature), CHILLS (Chills) and VACCINATION SITE PAIN (Injection site pain). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 09-Jan-2021, PAIN (Body aches) and CHILLS (Chills) had resolved. On 10-Jan-2021, VACCINATION SITE PAIN (Injection site pain) had resolved. At the time of the report, DYSGEUSIA (Odd taste in mouth) and FEELING HOT (Feverish feeling with no temperature) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Concomitant medications were provided

Other Meds:

Current Illness:

ID: 1572853
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: very sick; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very sick), CHILLS (chills) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (very sick), CHILLS (chills) and PYREXIA (fever). At the time of the report, ILLNESS (very sick), CHILLS (chills) and PYREXIA (fever) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment related information has been reported. Reporter did not allow further contact; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572854
Sex: M
Age:
State: NY

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: mildly sore on the arms on injection site; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PAIN (mildly sore on the arms on injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE PAIN (mildly sore on the arms on injection site). At the time of the report, VACCINATION SITE PAIN (mildly sore on the arms on injection site) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No Concomitant medications were provided No Treatment information provided

Other Meds:

Current Illness:

ID: 1572855
Sex: F
Age: 58
State: GA

Vax Date: 01/14/2021
Onset Date: 01/20/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VERTIGO (Vertigo). At the time of the report, VERTIGO (Vertigo) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Concomitant medications were provided Treatment information provided as "used pills for vertigo"

Other Meds:

Current Illness:

ID: 1572856
Sex: U
Age:
State:

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I couldn't move my arm; Hurting all the way into my shoulder blade; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (I couldn't move my arm) and ARTHRALGIA (Hurting all the way into my shoulder blade) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 20-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced LIMB DISCOMFORT (I couldn't move my arm) and ARTHRALGIA (Hurting all the way into my shoulder blade). At the time of the report, LIMB DISCOMFORT (I couldn't move my arm) and ARTHRALGIA (Hurting all the way into my shoulder blade) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Concomitant medications were provided No Treatment information provided

Other Meds:

Current Illness:

ID: 1572857
Sex: F
Age: 73
State: NC

Vax Date: 01/12/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: big red at the injection site; swollen at the injection site; tenderness; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (big red at the injection site), INJECTION SITE SWELLING (swollen at the injection site) and INJECTION SITE PAIN (tenderness) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 12-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 21-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (big red at the injection site), INJECTION SITE SWELLING (swollen at the injection site) and INJECTION SITE PAIN (tenderness). At the time of the report, INJECTION SITE ERYTHEMA (big red at the injection site), INJECTION SITE SWELLING (swollen at the injection site) and INJECTION SITE PAIN (tenderness) outcome was unknown.

Other Meds:

Current Illness:

ID: 1572858
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; A spontaneous report was received from a Consumer concerning patient of a unknown Age and gender who received Modern's COVID-19 vaccine (mRNA-1273) and experienced Chills. The patient's medical history was not provided. concomitant medication details were not provided. On unknown date, prior to the onset of the events, the patient received their second dose of two planned doses of mRNA-1273 (lot/batch: unknown). On unknown date, the patient experienced the events of Chills. No Laboratory details provided. No treatment information was provided Action taken with mRNA-1273 in response to the events was not reported. At the time of this report, the outcome of the events Chills is recovered.

Other Meds:

Current Illness:

ID: 1572859
Sex: F
Age: 72
State: TX

Vax Date: 01/06/2021
Onset Date: 01/14/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; Rash at the injection site; Nausea; Headache; red at the injection site.; itchy at the injection site; It was sore to touch/ injection site tenderness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE PAIN (It was sore to touch/ injection site tenderness), VACCINATION SITE RASH (Rash at the injection site) and NAUSEA (Nausea) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event (no medical history reported.). On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itchy at the injection site) and VACCINATION SITE PAIN (It was sore to touch/ injection site tenderness). On 15-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash at the injection site), NAUSEA (Nausea), HEADACHE (Headache) and VACCINATION SITE ERYTHEMA (red at the injection site.). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm), VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE PAIN (It was sore to touch/ injection site tenderness), VACCINATION SITE RASH (Rash at the injection site), NAUSEA (Nausea), HEADACHE (Headache) and VACCINATION SITE ERYTHEMA (red at the injection site.) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1572860
Sex: M
Age: 78
State:

Vax Date: 01/22/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; fever going from 99 to 100 and back down again; very achy; A Spontaneous report was reported was received from concerning a 78 years old, male patient who was administered by Modern's COVID-19 vaccine and an adverse event was reported. The patient's medical history was not known and patient is having questions regarding the use of Tylenol whether they should take it or what they can do. On 22 Jan 2021 ,of morning both patient and his wife received Moderna vaccine. On 23rd JAN 2021 patient reported severe chills and has a fever which went from 99 to 100 back down again . Patient was confused and don't know what to do. They both were very achy. Lot number 20A (patient didn't provided the rest of the lot number. No treatment information was provided. The adverse event ,reported by the patient was considered to be resolved.

Other Meds:

Current Illness:

ID: 1572861
Sex: F
Age: 70
State: IL

Vax Date: 01/10/2021
Onset Date: 01/11/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Throbbing feeling between temples; Pressure in head; Pain; Terrible headache; Aches; Barely turn neck; This spontaneous case was reported by a non-health professional and describes the occurrence of NECK PAIN (Barely turn neck), PAIN (Throbbing feeling between temples), HEAD DISCOMFORT (Pressure in head), PAIN (Pain) and HEADACHE (Terrible headache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced NECK PAIN (Barely turn neck), PAIN (Pain), HEADACHE (Terrible headache) and MYALGIA (Aches). On 12-Jan-2021, the patient experienced PAIN (Throbbing feeling between temples) and HEAD DISCOMFORT (Pressure in head). The patient was treated with IBUPROFEN ongoing since an unknown date for Adverse event, at a dose of UNK dosage form and PARACETAMOL (TYLENOL) ongoing since an unknown date for Adverse event, at a dose of UNK dosage form. At the time of the report, NECK PAIN (Barely turn neck), PAIN (Throbbing feeling between temples), HEAD DISCOMFORT (Pressure in head), PAIN (Pain), HEADACHE (Terrible headache) and MYALGIA (Aches) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1572862
Sex: F
Age: 69
State: AL

Vax Date: 01/05/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchiness; knot; minor rash; swollen arm at injection site; WARNING: THE STUDY CONFIGURATION IS MISSING THE STUDY PHASE. PLEASE UPDATE THE STUDY PHASE AND RE-GENERATE THE NARRATIVE AGAIN. This The subject received mRNA-1273 (Moderna COVID-19 Vaccine). The report describes a case of PRURITUS (Itchiness), VACCINATION SITE INDURATION (knot), VACCINATION SITE RASH (minor rash) and VACCINATION SITE SWELLING (swollen arm at injection site). No Medical History information was reported. On an unknown date, the patient experienced PRURITUS (Itchiness), VACCINATION SITE INDURATION (knot), VACCINATION SITE RASH (minor rash) and VACCINATION SITE SWELLING (swollen arm at injection site). At the time of the report, PRURITUS (Itchiness), VACCINATION SITE INDURATION (knot), VACCINATION SITE RASH (minor rash) and VACCINATION SITE SWELLING (swollen arm at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment included ice and heat.

Other Meds:

Current Illness:

ID: 1572863
Sex: F
Age:
State: CA

Vax Date: 01/16/2021
Onset Date: 01/23/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: got delayed allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (got delayed allergic reaction) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced ALLERGY TO VACCINE (got delayed allergic reaction). At the time of the report, ALLERGY TO VACCINE (got delayed allergic reaction) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information provided.

Other Meds:

Current Illness:

ID: 1572864
Sex: F
Age:
State: NY

Vax Date: 01/16/2021
Onset Date: 01/23/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Spreading and itchy; Red, Oval Itching spot at injection site; Little rise in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (Spreading and itchy), INJECTION SITE ERYTHEMA (Red, Oval Itching spot at injection site) and INJECTION SITE SWELLING (Little rise in the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced INJECTION SITE PRURITUS (Spreading and itchy), INJECTION SITE ERYTHEMA (Red, Oval Itching spot at injection site) and INJECTION SITE SWELLING (Little rise in the injection site). At the time of the report, INJECTION SITE PRURITUS (Spreading and itchy), INJECTION SITE ERYTHEMA (Red, Oval Itching spot at injection site) and INJECTION SITE SWELLING (Little rise in the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment medications were provided by the reporter.

Other Meds:

Current Illness:

ID: 1572865
Sex: F
Age: 65
State: TX

Vax Date: 01/12/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: a little sore arm; arm hurting, swollen; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (a little sore arm) and INJECTION SITE SWELLING (arm hurting, swollen) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) and DULAGLUTIDE (TRULICITY) for an unknown indication. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (a little sore arm) and INJECTION SITE SWELLING (arm hurting, swollen). At the time of the report, INJECTION SITE PAIN (a little sore arm) had not resolved and INJECTION SITE SWELLING (arm hurting, swollen) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment medications were provided by the reporter.

Other Meds: CRESTOR; TRULICITY

Current Illness:

ID: 1572866
Sex: F
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Terrible migraine headaches with aura; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE WITH AURA (Terrible migraine headaches with aura) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy (Tetracycline, Clindamycin). On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MIGRAINE WITH AURA (Terrible migraine headaches with aura). At the time of the report, MIGRAINE WITH AURA (Terrible migraine headaches with aura) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment medications were provided by the reporter.

Other Meds:

Current Illness:

ID: 1572867
Sex: F
Age: 65
State: PA

Vax Date: 01/23/2021
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Big circle around the injection site; red (circle); This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE DISCOLOURATION (Big circle around the injection site) and INJECTION SITE ERYTHEMA (red (circle)) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE DISCOLOURATION (Big circle around the injection site) and INJECTION SITE ERYTHEMA (red (circle)). At the time of the report, INJECTION SITE DISCOLOURATION (Big circle around the injection site) and INJECTION SITE ERYTHEMA (red (circle)) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment medications were provided by the reporter.

Other Meds:

Current Illness:

ID: 1572868
Sex: F
Age:
State:

Vax Date: 01/22/2021
Onset Date: 01/23/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Signs and symptoms/reaction to the moderna shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Signs and symptoms/reaction to the moderna shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION COMPLICATION (Signs and symptoms/reaction to the moderna shot). At the time of the report, VACCINATION COMPLICATION (Signs and symptoms/reaction to the moderna shot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment medications were provided by the reporter.

Other Meds:

Current Illness:

ID: 1572869
Sex: M
Age: 52
State: AZ

Vax Date: 01/31/2021
Onset Date: 01/31/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: shaking; fever; arm started to hurt; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN EXTREMITY (arm started to hurt), TREMOR (shaking) and PYREXIA (fever) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included LOSARTAN, DICLOFENAC SODIUM, LINUM USITATISSIMUM, MENTHOL, METHYL SALICYLATE, THIOCOLCHICOSIDE (INSTAFLEX) and CETIRIZINE HYDROCHLORIDE (ALLERTEC) for an unknown indication. On 31-Jan-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm started to hurt). On 01-Feb-2021, the patient experienced TREMOR (shaking) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm started to hurt) and TREMOR (shaking) outcome was unknown and PYREXIA (fever) was resolving. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds: LOSARTAN; INSTAFLEX; ALLERTEC

Current Illness:

ID: 1572870
Sex: F
Age: 50
State: CA

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: COVID 19; body aches; fever; cold symptoms; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold symptoms), COVID-19 (COVID 19), MYALGIA (body aches) and PYREXIA (fever) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination. Concomitant products included VITAMINS NOS for an unknown indication. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced NASOPHARYNGITIS (cold symptoms), MYALGIA (body aches) and PYREXIA (fever). On 24-Jan-2021, the patient experienced COVID-19 (COVID 19). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, NASOPHARYNGITIS (cold symptoms), COVID-19 (COVID 19), MYALGIA (body aches) and PYREXIA (fever) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: VITAMINS NOS

Current Illness:

ID: 1572871
Sex: M
Age: 77
State: GA

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Mild Headache; Low grade Fever of 100-101?C; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Mild Headache) and PYREXIA (Low grade Fever of 100-101?C) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced HEADACHE (Mild Headache) and PYREXIA (Low grade Fever of 100-101?C). At the time of the report, HEADACHE (Mild Headache) and PYREXIA (Low grade Fever of 100-101?C) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1572872
Sex: M
Age: 75
State: TX

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The patient's past medical history included Blood pressure. Concomitant products included OLMESARTAN MEDOXOMIL (BENICAR) for an unknown indication. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Reporter did not allow further contact

Other Meds: BENICAR

Current Illness:

ID: 1572873
Sex: F
Age: 55
State:

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Redness below injection site; It was hard; Warm; Itchy; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm), VACCINATION SITE ERYTHEMA (Redness below injection site), VACCINATION SITE INDURATION (It was hard), VACCINATION SITE WARMTH (Warm) and PRURITUS (Itchy) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. No Medical History information was reported. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 23-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness below injection site), VACCINATION SITE INDURATION (It was hard), VACCINATION SITE WARMTH (Warm) and PRURITUS (Itchy). The patient was treated with CEFALEXIN (CEPHALEXIN AMEL) ongoing since an unknown date at a dose of 500 mg two times per week. At the time of the report, VACCINATION SITE PAIN (sore arm) had resolved and VACCINATION SITE ERYTHEMA (Redness below injection site), VACCINATION SITE INDURATION (It was hard), VACCINATION SITE WARMTH (Warm) and PRURITUS (Itchy) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1572874
Sex: F
Age: 78
State: VA

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: A round circle, was dark red; Feels a bit warm; Arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm was sore), VACCINATION SITE ERYTHEMA (A round circle, was dark red) and VACCINATION SITE WARMTH (Feels a bit warm) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The patient's past medical history included Diabetes. Concomitant products included INSULIN GLARGINE (LANTUS), ATORVASTATIN, OLMESARTAN and LEVOTHYROXINE for an unknown indication. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm was sore). On 25-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (A round circle, was dark red) and VACCINATION SITE WARMTH (Feels a bit warm). On 16-Jan-2021, VACCINATION SITE PAIN (Arm was sore) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (A round circle, was dark red) and VACCINATION SITE WARMTH (Feels a bit warm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds: LANTUS; ATORVASTATIN; OLMESARTAN; LEVOTHYROXINE

Current Illness:

ID: 1572875
Sex: F
Age: 40
State: TX

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (exposure during pregnancy) in a 40-year-old female patient (gravida 5, para 3) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 024M20A) for COVID-19 vaccination. The patient's past medical history included Alcohol use (Casual drinker prior to pregnancy) on 01-Aug-2020, Pregnancy (still birth) on 06-Mar-2002, Pregnancy (Live,Full-term birth) on 16-Jan-2003, Pregnancy (Live, Full-term birth) on 25-Feb-2010 and Pregnancy (Live, Full-term birth) on 22-Sep-2013. Concomitant products included PRENATAL 1+1 FE from 09-Jan-2020 to an unknown date for Pregnancy, IRON (IRON ORAL) from 09-Feb-2021 to an unknown date for an unknown indication. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 03-Aug-2020 and the estimated date of delivery was 10-May-2021. On 12-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the twenty-third week of the pregnancy. On 12-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (exposure during pregnancy) had resolved. not provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Sep-2020, Pregnancy test: positive (Positive) Positive. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The patient underwent glucose tolerance test on 05 Feb 2021 and sonogram 01 Jan 2021, but results were not provided. The number of fetuses was reported as 1 and had established prenatal care. The patient had no complications and acute illness during this pregnancy to date. The patient had no maternal history of subfertility. No treatment information was provided.

Other Meds: PRENATAL 1+1 FE; IRON ORAL

Current Illness:

ID: 1572876
Sex: F
Age: 73
State: CA

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itchy; swollen 3 inches in size; redness; arm soreness; arm swollen; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness), PERIPHERAL SWELLING (arm swollen), PRURITUS (itchy), PERIPHERAL SWELLING (swollen 3 inches in size) and ERYTHEMA (redness) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041620A) for COVID-19 vaccination. Concomitant products included ATORVASTATIN for Cholesterol, ESTRADIOL for Hormone level abnormal, IBUPROFEN for Pain, CYANOCOBALAMIN, FOLIC ACID (VITAMIN B12 & FOLIC ACID), ASCORBIC ACID, BETACAROTENE, CUPRIC OXIDE, TOCOPHERYL ACETATE, ZINC OXIDE (PRESERVISION), CALCIUM, COLECALCIFEROL (CITRACAL CALCIUM PEARLS + D3) and POLYCARBOPHIL CALCIUM (FIBER) for Supplementation therapy, PREGABALIN for an unknown indication. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm soreness) and PERIPHERAL SWELLING (arm swollen). On 22-Jan-2021, the patient experienced PRURITUS (itchy), PERIPHERAL SWELLING (swollen 3 inches in size) and ERYTHEMA (redness). On 17-Jan-2021, PAIN IN EXTREMITY (arm soreness) and PERIPHERAL SWELLING (arm swollen) had resolved. At the time of the report, PRURITUS (itchy), PERIPHERAL SWELLING (swollen 3 inches in size) and ERYTHEMA (redness) outcome was unknown. Not provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: ATORVASTATIN; IBUPROFEN; ESTRADIOL; PREGABALIN; VITAMIN B12 & FOLIC ACID; PRESERVISION; CITRACAL CALCIUM PEARLS + D3; FIBER.

Current Illness:

ID: 1572877
Sex: F
Age:
State:

Vax Date: 01/18/2021
Onset Date: 01/24/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Head pain; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Head pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced HEADACHE (Head pain). At the time of the report, HEADACHE (Head pain) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1572878
Sex: F
Age: 50
State: OH

Vax Date: 12/24/2020
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Delayed reaction; vaccination site cellulitis; Induration at injection site; Redness at injection site; This spontaneous case was reported by a physician and describes the occurrence of SKIN REACTION (Delayed reaction), VACCINATION SITE CELLULITIS (vaccination site cellulitis), VACCINATION SITE INDURATION (Induration at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039k20A) for COVID-19 vaccination. No Medical History information was reported. On 24-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SKIN REACTION (Delayed reaction), VACCINATION SITE CELLULITIS (vaccination site cellulitis), VACCINATION SITE INDURATION (Induration at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site). At the time of the report, SKIN REACTION (Delayed reaction), VACCINATION SITE CELLULITIS (vaccination site cellulitis), VACCINATION SITE INDURATION (Induration at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1572879
Sex: M
Age: 72
State: FL

Vax Date: 12/30/2020
Onset Date: 12/30/2020
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Flushing on the face; Heart started to race; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (Flushing on the face) and PALPITATIONS (Heart started to race) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. No Medical History information was reported. On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced FLUSHING (Flushing on the face) and PALPITATIONS (Heart started to race). On 30-Dec-2020, FLUSHING (Flushing on the face) and PALPITATIONS (Heart started to race) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1572880
Sex: F
Age: 62
State: WA

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore right arm; Sored upoto her neck; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore right arm) and NECK PAIN (Sored upoto her neck) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. No Medical History information was reported. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore right arm) and NECK PAIN (Sored upoto her neck). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 20-Jan-2021, NECK PAIN (Sored upoto her neck) had resolved. On 21-Jan-2021, PAIN IN EXTREMITY (Sore right arm) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. Treatment details-patient took Tylenol on 20 Jan 2021.

Other Meds:

Current Illness:

ID: 1572881
Sex: M
Age: 59
State: CA

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hives appeared within 90 minutes of receiving the vaccine; Horrible rash all over his body; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives appeared within 90 minutes of receiving the vaccine) and RASH (Horrible rash all over his body) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. No Medical History information was reported. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced URTICARIA (Hives appeared within 90 minutes of receiving the vaccine) and RASH (Horrible rash all over his body). The patient was treated with METHYLPREDNISOLONE at an unspecified dose and frequency. At the time of the report, URTICARIA (Hives appeared within 90 minutes of receiving the vaccine) and RASH (Horrible rash all over his body) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. Treatment information mentioned stated methylprednisolone for one week.

Other Meds:

Current Illness:

ID: 1572882
Sex: F
Age:
State: OK

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Felt soreness in injection site on the day of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Felt soreness in injection site on the day of injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Felt soreness in injection site on the day of injection). At the time of the report, VACCINATION SITE PAIN (Felt soreness in injection site on the day of injection) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1572883
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (adverse reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VACCINATION COMPLICATION (adverse reaction). At the time of the report, VACCINATION COMPLICATION (adverse reaction) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment and concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1572884
Sex: F
Age: 80
State: PA

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: red blotch 2 in X 2 in. around the the injection site; injection site bump; injection site was tender; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (injection site was tender), VACCINATION SITE MASS (injection site bump) and VACCINATION SITE ERYTHEMA (red blotch 2 in X 2 in. around the the injection site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 1. On 15-Jan-2021, the patient experienced VACCINATION SITE PAIN (injection site was tender) and VACCINATION SITE MASS (injection site bump). On 17-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (red blotch 2 in X 2 in. around the the injection site). On 16-Jan-2021, VACCINATION SITE PAIN (injection site was tender) and VACCINATION SITE MASS (injection site bump) outcome was unknown. At the time of the report, VACCINATION SITE ERYTHEMA (red blotch 2 in X 2 in. around the the injection site) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. Treatment medication was not provided.

Other Meds:

Current Illness:

ID: 1572885
Sex: F
Age: 77
State: AL

Vax Date: 01/18/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itching at the injection arm; Redness at the injection arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching at the injection arm) and VACCINATION SITE ERYTHEMA (Redness at the injection arm) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 21-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection arm) and VACCINATION SITE ERYTHEMA (Redness at the injection arm). At the time of the report, VACCINATION SITE PRURITUS (Itching at the injection arm) and VACCINATION SITE ERYTHEMA (Redness at the injection arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1572886
Sex: F
Age: 66
State: OH

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm pain; Injection site red; induration at the injection site; Headache; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (Arm pain), VACCINATION SITE ERYTHEMA (Injection site red), VACCINATION SITE INDURATION (induration at the injection site) and HEADACHE (Headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. No Medical History information was reported. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm pain), VACCINATION SITE ERYTHEMA (Injection site red), VACCINATION SITE INDURATION (induration at the injection site) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Arm pain), VACCINATION SITE ERYTHEMA (Injection site red), VACCINATION SITE INDURATION (induration at the injection site) and HEADACHE (Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1572887
Sex: F
Age: 60
State: ID

Vax Date: 01/17/2021
Onset Date: 01/25/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: redness on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness on the injection site) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness on the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (redness on the injection site) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications reported by investigator o No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1572888
Sex: M
Age: 48
State: NJ

Vax Date: 01/23/2021
Onset Date: 01/23/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: blurred vision; joints hurt; High pressure (went up repeatedly); This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPERTENSION (High pressure (went up repeatedly)), VISION BLURRED (blurred vision) and ARTHRALGIA (joints hurt) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Blood pressure since an unknown date. On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, the patient experienced HYPERTENSION (High pressure (went up repeatedly)). On an unknown date, the patient experienced VISION BLURRED (blurred vision) and ARTHRALGIA (joints hurt). At the time of the report, HYPERTENSION (High pressure (went up repeatedly)) had not resolved and VISION BLURRED (blurred vision) and ARTHRALGIA (joints hurt) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, Blood pressure measurement: 6.11 left the hospital with a pressure of 6.11 but in the night it rose from 9 to 25.. On 25-Jan-2021, Computerised tomogram: normal. On 26-Jan-2021, Blood pressure measurement: 22 pressure went up to 22. On 27-Jan-2021, Blood pressure measurement: 23. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Patient take Medication for the pressure

Other Meds:

Current Illness: Blood pressure

ID: 1572889
Sex: F
Age: 66
State:

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: side effects; This spontaneous case was reported by a consumer and describes the occurrence of in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history.). On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator o No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1572890
Sex: F
Age: 71
State: OK

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pain injection site; aches all over her body; felt like I was hit by a truck; heart rate was faster than normal; This spontaneous case was reported by a consumer and describes the occurrence of in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The patient's past medical history included COVID-19 in April 2020. Concomitant products included METOPROLOL for Heart rate increased. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: METOPROLOL

Current Illness:

ID: 1572891
Sex: F
Age: 65
State: NY

Vax Date: 01/16/2021
Onset Date: 01/17/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchy Sensation Near the Injection Site; Discomfort near injection site; Swelling near Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (Discomfort near injection site), VACCINATION SITE SWELLING (Swelling near Injection Site) and VACCINATION SITE PRURITUS (Itchy Sensation Near the Injection Site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20) for COVID-19 vaccination. No Medical History information was reported. On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced VACCINATION SITE DISCOMFORT (Discomfort near injection site) and VACCINATION SITE SWELLING (Swelling near Injection Site). On 24-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy Sensation Near the Injection Site). At the time of the report, VACCINATION SITE DISCOMFORT (Discomfort near injection site), VACCINATION SITE SWELLING (Swelling near Injection Site) and VACCINATION SITE PRURITUS (Itchy Sensation Near the Injection Site) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications reported by investigator o No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1572892
Sex: F
Age:
State: LA

Vax Date: 01/21/2021
Onset Date: 01/23/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: a rash on the back of her shoulders, from one to the other, painful, burning, not itchy; This spontaneous case was reported by a pharmacist and describes the occurrence of RASH (a rash on the back of her shoulders, from one to the other, painful, burning, not itchy) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032LC0A) for COVID-19 vaccination. The patient's past medical history included No adverse event (no reported medical history). Concomitant products included NABUMETONE (RELAFEN) and NABUMETONE for an unknown indication. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced RASH (a rash on the back of her shoulders, from one to the other, painful, burning, not itchy). On 24-Jan-2021, RASH (a rash on the back of her shoulders, from one to the other, painful, burning, not itchy) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Patient take Solution of Witch-hazel and 3 Benadryl as a treatment medication

Other Meds: RELAFEN; NABUMETONE.

Current Illness:

ID: 1572893
Sex: M
Age: 51
State: MD

Vax Date: 12/28/2020
Onset Date: 01/03/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Diagnosed with COVID; This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (Diagnosed with COVID) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. No Medical History information was reported. On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jan-2021, the patient experienced COVID-19 (Diagnosed with COVID). At the time of the report, COVID-19 (Diagnosed with COVID) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications reported by investigator o No treatment medications provided by the reporter.

Other Meds:

Current Illness:

ID: 1572894
Sex: F
Age: 55
State: FL

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: right arm was a little sore the next day; redness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), MINERALS NOS, VITAMINS NOS (MULTIVITAMIN AND MINERAL SUPPLEMENT) and OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]) for an unknown indication. On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: BABY ASPIRIN; MULTIVITAMIN AND MINERAL SUPPLEMENT; PRILOSEC [OMEPRAZOLE MAGNESIUM]

Current Illness:

ID: 1572895
Sex: F
Age: 67
State: MN

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hives; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE URTICARIA (Hives) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included MULTI VITAMINS & MINERALS for an unknown indication. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE URTICARIA (Hives). The patient was treated with PREDNISONE at an unspecified dose and frequency; CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency and FAMOTIDINE (PEPCID AC) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE URTICARIA (Hives) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: MULTI VITAMINS & MINERALS

Current Illness:

ID: 1572896
Sex: M
Age:
State: FL

Vax Date: 01/04/2021
Onset Date: 01/18/2021
Rec V Date: 08/16/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: red at near the injection site/red 3 inch wide; swollen; soreness; Itching around the arm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching around the arm), VACCINATION SITE ERYTHEMA (red at near the injection site/red 3 inch wide), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE PAIN (soreness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history). On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced PRURITUS (Itching around the arm). On 19-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (red at near the injection site/red 3 inch wide), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE PAIN (soreness). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 22-Jan-2021, PRURITUS (Itching around the arm), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE PAIN (soreness) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (red at near the injection site/red 3 inch wide) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm